Loading

General practitioners (GPs) often lack time and resources to invest in health education; audiovisual messages broadcast in the waiting room may be a useful educational tool. This work was designed to assess the effect of a message inviting patients...

Vaccination of pregnant women with a pertussis containing vaccine is a recommended strategy in some industrialized countries, to protect young infants from severe disease. One of the effects of the presence of high titers of passively acquired...

The burden of invasive pneumococcal disease in young children decreased dramatically following introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). The epidemiology of S. pneumoniae now reflects infections caused by serotypes not...

The effectiveness of childhood immunization programs depends on the vaccination coverage actually achieved. Routinely collected coverage data are not always available, and comparability between countries is often compromised because of different...

Despite long-standing two-dose measles-mumps-rubella (MMR) vaccination, measles outbreaks still occur in highly vaccinated European populations. For instance, large measles outbreaks occurred in France (2008–13), the United Kingdom (2012–13) and...

Rotavirus gastroenteritis is a vaccine-preventable disease that confers a high medical and economic burden in more developed countries and can be fatal in less developed countries. Two vaccines with high efficacy and good safety profiles were...

The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the...

Forum Post

Have you included pharmacists in your immunization plan?

April 07th 2017

Dear TechNet-21 Community, For many years, pharmacists have been involved in supply chain and supporting campaigns to support immunization by patients, but they are more and more i

  • Organisation: WHO
  • Country: Switzerland South Africa Portugal Philippines Ireland France Belgium Australia Argentina
  • Distribution system HR
  • Forum Post

    Tanzania leading the way with barcodes on vaccine packaging

    May 08th 2013

    by Daniel Thornton, GAVI; Henry Mwanyika, PATH; Drew Meek, WHO; Ulrike Kreysa, GS1 A project in Tanzania is exploring how best to implement barcodes on vaccine packaging. By adding barcodes to the

  • Country: Belgium
  • Disease: Rubella Mumps Measles
  • Optimize Barcode
  • Forum Post

    Immunization Practices Advisory Committee: Members and Meeting Agenda

    June 08th 2010

    WHO/IVB is very pleased to announce the members of the Immunization Practices Advisory Committee (IPAC): Chair: Shelley DEEKS – Medical Epidemiologist – Ontario Agency for Health Protecti

  • Country: Switzerland Nigeria Niger Jordan Belgium
  • Event
  • Forum Post

    New bivalent polio vaccine simplifies logistics in hard-to-reach areas

    February 24th 2010

    New bivalent polio vaccine simplifies logistics in hard-to-reach areas[i]by Ian Lewis, UNICEF Supply Division[/i] Since 2005, the [url=http://www.polioeradication.org/]Global Polio Eradication Initiat

  • Country: Nigeria Niger India Belgium Afghanistan
  • Disease: Polio
  • Forum Post

    POST 00712E : ACCIDENTAL NEEDLESTICK

    August 31st 2004

    POST 00712E : ACCIDENTAL NEEDLESTICK Follow-up on Posts 00701E, 00706E and 00708E 31 August 2004 _____________________________________ Two more contributions were received on this topic. The

  • Country: India Canada Belgium
  • Injection safety
  • Forum Post

    Forum Post

    Post00343 VACCINE FREEZING: WHY IS THE COLD CHAIN TOO COLD?

    May 20th 2001

    Post00343 VACCINE FREEZING: WHY IS THE COLD CHAIN TOO COLD? 20 May 2001 CONTENTS 1. WHY IS THE COLD CHAIN TOO COLD? MORE..... 2. HEP-B OUT OF THE COLD CHAIN? 3. VVMs ON VACCINES 1. WHY I

  • Country: Senegal Japan Italy Indonesia India Hungary France Egypt Denmark Cambodia Bulgaria Belgium
  • Disease: Yellow fever Measles Hepatitis B HIB TB
  • Vaccine management
  • Forum Post

    Post00327 : GAVI YEAR END REPORTS 2000

    March 02nd 2001

    Post00327 GAVI YEAR END REPORTS 2000 2 March 2001 CONTENTS 1. GAVI DOCUMENT DISSEMINATION 2. GAVI AND THE GLOBAL FUND FOR CHILDREN'S VACCINES: ONE YEAR LATER 3. PARTNERS' MEETING NOVEMBER 20

  • Country: United States Senegal Norway Netherlands Mali Indonesia India Ghana Cuba China Burkina Faso Brazil Belgium
  • Disease: Yellow fever Tuberculosis Tetanus Rotavirus Pertussis Measles Malaria Hepatitis B Diphtheria Polio HIB
  • Forum Post

    Post00327 : GAVI YEAR END REPORTS 2000

    March 02nd 2001

    Post00327 GAVI YEAR END REPORTS 2000 2 March 2001 CONTENTS 1. GAVI DOCUMENT DISSEMINATION 2. GAVI AND THE GLOBAL FUND FOR CHILDREN'S VACCINES: ONE YEAR LATER 3. PARTNERS' MEETING NOVEMBER 20

  • Country: United States Senegal Norway Netherlands Mali Indonesia India Ghana Cuba China Burkina Faso Brazil Belgium
  • Disease: Yellow fever Tuberculosis Tetanus Rotavirus Pertussis Measles Malaria Hepatitis B Diphtheria Polio HIB
  • Forum Post

    Post00327 : GAVI YEAR END REPORTS 2000

    March 02nd 2001

    Post00327 GAVI YEAR END REPORTS 2000 2 March 2001 CONTENTS 1. GAVI DOCUMENT DISSEMINATION 2. GAVI AND THE GLOBAL FUND FOR CHILDREN'S VACCINES: ONE YEAR LATER 3. PARTNERS' MEETING NOVEMBER 20

  • Country: United States Senegal Norway Netherlands Mali Indonesia India Ghana Cuba China Burkina Faso Brazil Belgium
  • Disease: Yellow fever Tuberculosis Tetanus Rotavirus Pertussis Measles Malaria Hepatitis B Diphtheria Polio HIB
  • We don't have any events
    We don't have any jobs
    No hot topics found!